Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

Published:2019-07 Issue:7 Volume:14 Page:1244-1254
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hendriks Lizza E.L.,Henon Clemence,Auclin Edouard,Mezquita Laura,Ferrara Roberto,Audigier-Valette Clarisse,Mazieres Julien,Lefebvre Corentin,Rabeau Audrey,Le Moulec Sylvestre,Cousin Sophie,Duchemann Boris,le Pechoux Cecile,Botticella Angela,Ammari Samy,Gazzah Anas,Caramella Caroline,Adam Julien,Lechapt Emmanuèle,Planchard David,De Ruysscher Dirk,Dingemans Anne-Marie,Besse Benjamin

Funder

Roche

Boehringer Ingelheim

AstraZeneca

Bristol-Myers Squibb

BMS

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer;Peters;Cancer Treat Rev,2016

2. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

3. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

4. Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden;Hellmann;N Engl J Med,2018

5. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function;Nature Communications;2024-09-05

3. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;CLIN LUNG CANCER;2024

4. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;Clinical Lung Cancer;2024-09

5. The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study;Cancer Management and Research;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3